Egenix, Inc.
Records under this name other than patents Egenix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Egenix, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,537,558 | Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,602,526 | Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,409,901 | Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E Formerly held Lapsed on the fee record Ended Aug 9, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 9, 2020 | From the USPTO record |
| US 5,545,532 | Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging Term ended Term ended no later than Aug 13, 2016 · Low confidence | Term ended | Term ended no later than Aug 13, 2016 | Low confidence |